SQUID
Commercial- Indications
- Arteriovenous malformations
Company intelligence / Profile preview
Embo-Flüssigkeiten
Gland, Vaud, Switzerlandbioalps.org ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Embo-Flüssigkeiten manufactures and sells SQUID, a liquid embolic agent used in radiology and interventional neuroradiology for the treatment of vascular malformations such as AVMs. The product is CE-certified and distributed internationally. No clinical trial data or drug development pipeline typical for biotech/pharma companies; this is a commercial-stage medical device firm.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- DeviceLiquid embolic agent
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Embo-Flüssigkeiten.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Embo-Flüssigkeiten.